Detlef Eisenkrätzer Pharma Biotech Production & Development

Similar documents
Single-Use Bioreactors Meeting BioPharma Needs for Lower Operating Cost and Faster Time to Market

PARALLEL AUTOCLAVABLE MINI FERMENTERS/ BIOREACTORS

Application Note USD3013. Monoclonal Antibody Production in Suspension CHO Culture Using Single-Use PadReactor Mini Bioreactor

Use of the ambr 250 in combination with high-throughput design and analysis tools for rapid, scalable USP development

FLUID FLOW AND MIXING IN BIOREACTORS (Part 2 of 2)

Introducing: BioXpert. Supervisory Control and Data Acquisition Software

Siemens AG Case Study July Bioreactors

BioProcessing J O U R N A L. Trends and Developments in BioProcess Technology. Volume 9 Issue 1 ISSN

Eden Biodesign ebook Monoclonal Antibody Production: Building the Platform

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

Triskel: a strategic consulting firm for biopharmaceutical companies

Process Performance Qualification. Demonstrating a High Degree of Assurance in Stage 2 of the Process Validation Lifecycle

Cells and cell cultivation

Workshop on process validation

Bioprocessing Media and Buffers Grow with Us

Respiration Worksheet. Respiration is the controlled release of energy from food. Types of Respiration. Aerobic Respiration

Luca Romagnoli, Ph.D. Business Development Manager

Instrument services for WAVE Bioreactor systems

Economical Approaches to Meeting Global Demand for High Value Biopharmaceuticals

Dr.ssa Maria Luisa Nolli CEO

LFB GROUP & SANOFI combine their bioproduction capabilities to provide integrated CMO services for biopharmaceuticals

High yield antibody production in a disposable WAVE Bioreactor

Liquid II Cell Culture Media Manufacturing Plant. Overview Facilities Water for Injection Sterile Environment Media Handling Cleanroom Interior

Conductivity Sensor Calibrations to Meet Water Industry Requirements

Discover Configurable BioProcessing Solutions

Engineering for the new pharma reality

Accelerating Antibody Process Development: Exploring the Synergies Between Engineered Host Cells and Process Development

Mixing, mass transfer and bioprocess scaling up and down in new generation single-use bioreactors. Nico Oosterhuis CELLution Biotech

Valentina Gualato, Ph.D. Process Development Scientist

Challenges in the cgmp Manufacturing of hescs: Lessons Learned from Monoclonal Antibodies

QbD based Development and Characterization of a Cell Culture Process for Therapeutic Proteins

Biotechpharma company profile

Terry Blevins Principal Technologist Emerson Process Management Austin, TX

PlantForm Corporation

Solution business process automation

GMP Issues for Start-Ups, quality in the supply chain and role of the Qualified Person (QP)

Series 6000 Torque measured metal bellow coupling

Vaccine Manufacturing Facilities of the Future. Howard L. Levine, Ph.D. Vaccines Europe London, England December 1 2, 2010

High pressure reactors Where are your limits?

Accuracy and Pharmacutical

Multiple Products in a Monoclonal Antibody S88.01 Batch Plant

Technology Transfer of CMC Activities for MAb Manufacturing ge healthcare (

Biomanufacturing Vision for the Future

How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs


Highly Potent APIs The right platform, people and procedures for successful development and manufacturing

OECD and US GLP Applications. Del W. Huntsinger. BASF, Reserach Triangle Park, USA

The Paperless QMS March 2012

HAZARD ANALYSIS CRITICAL CONTROL POINT PLAN SUMMARY SETHNESS PRODUCTS COMPANY LIQUID CARAMEL COLOR

"Small and large molecules bioproduction by mammalian and microbial fermentation"

ACL 395 Resistivity Meter

Global Lab Capabilities Pharma Biotech

Single-Use Flow-Through Cell ph FTC-SU-HP8

Responsibilities of Test Facility Management & Sponsor Rik Hendriks Werner Coussement

Testing Automated Manufacturing Processes

Zeta Automation. Automation for pharma industry.

Ground Resistance Clamp On Tester

The Importance of Developing a High Yield of Product

Density and Refractometry

G4 ICARUS HF. Innovation with Integrity. Simultaneous Determination of Carbon and Sulfur in Solids. Combustion Method

Poultry manure as a substrate for methane fermentation: problems and solutions

Next-Generation Facilities for Monoclonal Antibody Production

Enhanced calibration High quality services from your global instrumentation partner

Integration of a disposable system in a traditional manufacturing process to terminal sterilization

Customized Nutritional Solutions For Laboratory Animals

Monoclonal Antibody Production: Building the Platform. Andrew Clutterbuck Eden Biodesign Ltd.

Compact ph Measuring Instruments

Series 7500 Torque Sensor

International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation

The Sievers 900 Series TOC Analyzers

I. PURPOSE This SOP describes policies, procedures, and record keeping requirements for all documents subject to change control.

Exciting Trends in Bioprocessing

FOOD SAFETY MANAGEMENT SYSTEMS (FSMS): REQUIREMENTS FOR ANY ORGANISATION IN THE FOOD CHAIN (ISO 22000:2005)

NEW CHEMICAL ENTITIES

Good Manufacturing Practices for the Production of Packaging Inks formulated for use on the non food contact surfaces of food packaging and articles

PTB 311E Manual 3-in-1 Tablet Testing Instrument

Electronic pressure switch with display Model PSD-30, standard version Model PSD-31, with flush diaphragm

GOOD LABORATORY PRACTICE (GLP)

Operating Principle of the Sample Positioning Flaps

Engineering Standards Advance PAT

JANUARY 2013 PREPARATION OF A SITE MASTER FILE FOR A MANUFACTURER OF COSMETIC PRODUCTS

ORBISPHERE M1100: CUSTOMER SUCCESS STORY - CARLSBERG

804 Ti Stand. Manual EN

Environmental Chamber. Stability/ GMP 2000 Series. Stability Testing Chambers

Manufacturing process of biologics

From Research Services and Process Development to GMP Manufacturing

Inverters. The product range.

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

Advancements in Modularization

ix3m Dive Computer Installable Apps Manual ver. 1.0

RIA : 2013 Market Trends Webinar Series

Your Guide to Upstream Processing Solutions From Research to Production

Resolution selectable from 0.01 and ph. Range ph. Accuracy ± ph

450TOC Analyzer. Portable, Real-time, Continuous Total Organic Carbon Measurement. 450TOC Analyzer

PART 1 - INTRODUCTION...

Advances in Biopharmaceutical and Vaccine Manufacturing Plants

Environmental Equipment, Inc. IMR 5000 Continuous Flue Gas Monitoring System IMR 5000

Risk-Based Change Management Using QbD Principles

Maximize Your Up Time With A Preventative Maintenance Plan Designed For The Way you Work s s s s.

Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant

Transcription:

Speed up Process Development by Implementation of new Bioreactor & Information Technology Detlef Eisenkrätzer Pharma Biotech Production & Development picture placeholder

Topics 1. Roche s Activity to Expand its R&D Capacity 2. Focus of Technology Evaluation 3. Evaluation of Single Use Bioreactors (SUB) Engineering Characterization Methods & Results Performance of Rockers for Seed Train Cultivation Process Performance of Stirred SUBs for Material Supply Rating of Control & Bag Systems for Stirred SUBs Single Use Sensors fit Optimal to SUB Technology 4. One IT-System to Manage & Analyze Informations 5. Lessons learned 2

Roche s Activity to Expand its R&D Capacity project Therapeutic Proteins - Expand started in January 2008 ~ 172 Mio for expansion of biotech R&D to support the therapeutic protein pipeline cost effective expansion of capacity acceleration of GLP-TOX and phase 1 supply increase flexibility to changing demands establish a transfer platform from research to clinical supply evaluation of new technologies to fulfill goals - = > concentration on single use technology to build up process platforms & paper less IT-system to speed up transfer of processes Roche site Penzberg in upper Bavaria 3

Calculation of Scope for Animal Cell based Processes # of new biotherapeutics to be launched per year attrition rate in clinical development # of TOX & phase 1 studies per year average demand of proteins / antibodies per phase average product titer in current & future processes ~ 3 batches to be done per supply campaign bioreactor size for supply platform: 250 L working volume expansion of existing bioreactor capacity by 27 bioreactors (incl. seed trains): for process transfer to 10 kl bioreactors as supply platform for non clinical & clinical development to supply technical development plus many 2 L bioreactors for process validation & PAT 4

Focus of Technology Evaluation 1. test different SUBs in different departments to ensure objective results combine automation & bag systems in different variants whenever possible to evaluate both components separately 2. evaluate tools to increase equipment utilization validated single use sensors with high reliability & accuracy optimal connectors for connection steel/plastic and plastic/plastic 3. install a new IT-system for all labs & plants to collect all data on line and archive data in centralized data bases to support interpretation of results and automate reporting integrate existing & new process equipment e of all plants in one PCS avoid efforts for data mining and support automated & mainly paperless process transfer between labs & plants More time for our core business - to develop new products, not asset management & data mining! 5

Evaluation of Single Use Bioreactors 6

Engineering Characterization - Methods determination of engineering numbers to compare technical performance of SUBs with Stainless Steel Bioreactors (SSB). suitability for scale up studies prognosis of limitations by poor substrate distribution, O 2 -supply and CO 2 removal delivery of data for dimensioning of energy supply for new plants resistance number of impeller & POWER INPUT by torque measurement (dismounting of stirrer drives and installation of torque meters) MIXING TIME by decolourization method OXYGEN TRANSFER COEFFICIENTS k L a by dynamic method (gas in/out) 7

Engineering Characterization - Results POWER INPUT of all SUBs is to low for scale up MIXING TIME and OXYGEN TRANSFER COEFFICIENT of rocking bioreactors are to low for main fermentations with high cell density & concentrated feeds every vendor of stirred SUBs has at least one bag type with acceptable MIXING TIME and k L a (if O 2 is used to increase the oxygen transfer rate) 8

Performance of Rockers for Seed Train Cultivation Viable Cell D ensity Cell Diam meter SUB Classical Classical SUB Classical Viability 17 parallel fermentations (compared to stainless steel vessels) showed identical results for: growth & productivity cell size distribution apoptosis formation of byproducts main differences between systems related to control system & single use sensor technology: no workaround with classical sensors less clean benches needed in plant no penetration of bag => higher reliability DO & ph controllers with recalibration functionality for optical sensors SUB system with plug & play functionality replaces all our classical seed bioreactors 9

Process Performance of Stirred SUBs for Mt Material ilsupply 100,0 Homogenization Number, Disposable Reaktor (1 PBT) in Comparison to 100L Model Reactor (3 PBT) CH ~ 74,8 CH ~ 54,0 CH ~ 34,33 CH ~ 35,1 CH ~ 59,1 CH [-] 10,0 Disposable Reaktor, 250L Disposable Reaktor, 200L Disposable Reaktor, 150L Disposable Reaktor, 125L 100L, 3 SBR 1,0 1,0E+04 Re [-] 10 1,0E+05

Process Performance: Control & Bag Systems control system Control System I bag system SUB 1 with 1 bag type Control System II Control System III SUB 2 with 3 different bag types Control System IV SUB 3 with 2 different bag types Control System V SUB 4 with 2 different bag types differences between control systems: integration of optical sensors based on network or local control based on WinCC or DCU or DeltaV differences between bag types: availability of optical sensors sparger types (micro/macro sparger) stirrer (Rushton, inclined impeller, paddle) 11

Process Performance - Examples antibody #9: tox study supply SUB #2: bag 2b without problems SUB #3: problems with accuracy of ph-sensor SUB #4: max. working volume reduced by foaming cells are clumping in bag 4a 12

Process Performance Product Titer of > 40 Fermentations 13

Process Performance Product Quality analysis of supply campaigns of 6 different therapeutic proteins from SUBs o product was always comparable to classic bioreactors regarding IEC- & glycosylation pattern until now no differences in product quality between products from classical fermentations & fermentations in SUBs have been observed analysis for endotoxins & bioburden are unremarkable influence of extractable & leachable substances must be excluded by use of certified materials (USP <88> Cl. VI) surprising - not all vendors have these certificates for their products available 14

Rating of Control & Bag Systems for Stirred SUBs 15

Single Use Sensors fit Optimal to SUB Technology rocking systems are used for seed train cultivation cultivation time is relatively short & culture is light protected sensor drift is in acceptable range stirred SUB systems for main cultivation sensors are not light sensitive (DO) or protected (ph) insignificant/no sensor drift sensors are pre-calibrated and ready to use grounded single use sensors deliver better signals 50.0 45.0 40.0 35.0 30.00 25.0 20.0 15.0 10.0 5.0 Single Use DO Single Use Temp Electrochemical DO RTD 0 0 24.000 48.000 72.000 96.000 120.000 144.000 168.000 192.000 216.000 240.000 264.000 288.000 Batch Duration (Hours) 16

One IT-System to Manage & Analyze Informations * 3 different IT architectures & process control systems have been evaluated 17

The IT-Architecture respects Different Requirements Research NonGMP-Dev. Process Validation Supply Phase I&II 18

Increased Efficiency by new Process Control Systems all data enter our data bases automatically the only operator inputs are comments & signatures all data on raw materials & consumables (and their performance) are stored centralized & ready for analysis reduced or no effort for sensor calibration and maintenance only single use sensors enable the reduction of change over time of the bioreactors features of the process control system like process save&load ease process transfer and reproduction of successful runs genealogy between processes & availability of data supports the generation of process knowledge estimated savings per operator/engineer: 210 hours/year 19

Combined Process Technology & IT-Project: Lessons learned 1. The involvement of the end-user is very intense compared to a project for stainless steel equipment with standard automation, where many aspects are routinely handled by engineering departments. 2. A highly detailed user requirement specification is needed, as many options exist for the different technical solutions. 3. Vendor audits should be done in early project phases as critical issues are related to QA-systems and company resources. 4. Close cooperation with supplier is recommended to ensure that the product fulfills the requirements (e.g. weekly meetings or telephone conferences). project team TP-Expand 20

Special Thanks to the SUB Project Team: Frank Trach & Elodie De Roo (Pharma Biotech Production) Wolfgang Paul & Roman Hirschauer & Rainer Reithmeier & Marion Traverse & Kurt Lang (Pharma Tech. Research) Alexander Herrmann & Gero Lipok (Pharma Tech. Development GMP) Ulrike Caudill & Olivier Guilmaille (Pharma Tech. Development NonGMP) Erwin Obersteiner & Philipp Kühne (Roche Automation) Patrick Vogel & Matthias Schmidt (Roche Process Engineering) Klaus Hermansen & Niels Guldager (nne pharmaplan) 21

We Innovate Healthcare 22